Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
15.06
-0.25 (-1.63%)
At close: Oct 13, 2026, 4:00 PM EDT
15.06
0.00 (0.00%)
After-hours: Oct 13, 2026, 4:10 PM EDT
AAPG Market Cap
AAPG has a market cap or net worth of $1.35 billion as of October 13, 2026. Its market cap has decreased by 60.61% in one year.
Market Cap
1.35B
Enterprise Value
1.38B
1-Year Change
-60.61%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on January 24, 2025, AAPG's market cap has decreased from $1.48B to $1.35B, a decrease of -8.96%. That is a compound annual growth rate of -5.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.35B | -45.34% |
| Dec 31, 2025 | 2.47B | 66.57% |
| Jan 24, 2025 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Omeros | 1.44B |
| Nektar Therapeutics | 1.41B |
| Inhibrx Biosciences | 1.40B |
| AnaptysBio | 1.37B |
| Kardigan | 1.37B |
| Tyra Biosciences | 1.37B |
| Alpha Tau Medical | 1.33B |
| Damora Therapeutics | 1.30B |